| Business Summary | | aaiPharma
Inc.,
formerly
Applied
Analytical
Industries,
Inc.,
is
a
specialty
pharmaceutical
and
product
life
cycle
management
company
with
comprehensive
drug
development
capabilities
in
the
United
States,
Europe
and
Asia.
The
core
services
provided
on
a
fee-for-service
basis
to
pharmaceutical
and
biotechnology
industries
worldwide
include
comprehensive
formulation,
testing
and
manufacturing
expertise,
in
addition
to
the
ability
to
take
investigational
products
into
and
through
human
clinical
trials.
The
product
sales
business
provides
for
the
production
of
clinical
trials
materials
for
Phase
I
through
IV
clinical
trials
and
the
outsourcing
of
commercial
manufacturing
of
small-quantity
products
for
other
pharmaceutical
companies.
In
the
product
development
segment,
the
Company
internally
develops
drugs
and
technologies
with
the
objective
of
licensing
marketing
rights
to
third
parties
in
exchange
for
license
fees
and
royalties. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | aaIPharma
Inc.
provides
product
development
and
support
services
on
a
contract
basis
for
pharmaceutical
companies
and
the
development
of
select
generic
drugs
and
improved
formulations
of
marketed
drugs.
For
the
six
months
ended
6/30/01,
revenues
rose
13%
to
$60
million.
Net
income
before
accouting
change
fell
25%
to
$1.8
million.
Results
reflect
higher
research
revenues.
Earnings
were
offset
by
increased
direct
costs
and
a
$1.7
million
pharmaceutical
start-up
expense. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Frederick Sancilio, 51 Chairman,
Pres and CEO | $410K | William Ginna, Jr., 48 CFO,
VP | -- | William Underwood, 53 Exec.
VP- Corp. Devel. and Licensing, Director | -- | Gregory Bentley, 51 Exec.
VP, Gen. Counsel, Sec. | 203K | David Johnston, Ph.D., 50 Exec.
VP- Non-clinical Operations | 266K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|